Combination CBD/THC in the management of chemotherapy-induced peripheral neuropathy: a randomized double blind controlled trial

IntroductionChemotherapy-induced peripheral neuropathy (CIPN) can greatly impair function, leading to disability or truncated treatment in cancer patients. Previous animal studies show that cannabidiol (CBD) and delta-9- tetrahydrocannabinol (THC) can ameliorate CIPN. This study assessed the effect...

Description complète

Détails bibliographiques

Auteurs principaux:	Marisa Weiss, Muath Giaddui, Stephanie Kjelstrom, Joseph Gary, Sara Jane Ward, Jessica Burrell, Katherine Diguilio, Gabrielle Bidas, Ebuwa Erebor, Sam Meske, Lisa Saeed, Sarah Windawi, Katherine Aliano Ruiz, Arezoo Ghaneie, Julianne Hibbs, John Marks, David Holtz, Zonera Ali, Aarthi Shevade, Jennifer Sabol, Robin Ciocca, Eric Zeger, Paul Gilman, Sharon Larson, Shoichi Shimamoto, Diana Martinez
Format:	Artigo
Langue:	Inglês
Publié:	Frontiers Media S.A. 2025-10-01
Collection:	Frontiers in Oncology
Sujets:	chemotherapy-induced peripheral neuropathy cannabinoids cannabidiol (CBD) delta-9-tetrahydrocannabinol (THC) sensory impairment cancer
Accès en ligne:	https://www.frontiersin.org/articles/10.3389/fonc.2025.1590168/full
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!